PMID: 22584369May 16, 2012Paper

Evaluation of the methodological quality of the Health Protection Agency's 2009 guidance on neuraminidase inhibitors

Quality in Primary Care
Kevork Hopayian, Lucy Jackson

Abstract

The Health Protection Agency (HPA) issued guidance advocating the prescription of neuraminidase inhibitors in July 2009 in response to a predicted pandemic of influenza. Although the contents of the guidance have been debated, the methodology has not. The guidance was evaluated by two reviewers using a validated and internationally recognised tool for assessing guidelines, the Appraisal of Guidelines Research & Evaluation instrument (AGREE). This tool scores six domains independently of each other. The guidance scored 61% for the domain scope and purpose and 54% for the domain clarity and presentation. By contrast, it scored only 31% for rigour of development due to poor linkage of its recommendations to evidence. The HPA should improve its performance in this domain to general practitioners in order to improve the credibility of its future guidance.

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Journal of Nursing Scholarship : an Official Publication of Sigma Theta Tau International Honor Society of Nursing
Barbara Jo FoleyCarolyn C Kee
European Review for Medical and Pharmacological Sciences
S BucherD Ribuffo
© 2021 Meta ULC. All rights reserved